Screener
Axsome Therapeutics AXSM Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Axsome Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Axsome Therapeutics’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 5:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204274
FAQ
- What is Axsome Therapeutics's gross margin?
- Axsome Therapeutics (AXSM) reported gross margin of 92.6% in Q1 2026.
- How has Axsome Therapeutics's gross margin changed year-over-year?
- Axsome Therapeutics's gross margin increased by 1.2% year-over-year, from 91.5% to 92.6%.
- What is the long-term trend for Axsome Therapeutics's gross margin?
- Over 3 years (2022 to 2025), Axsome Therapeutics's gross margin has grown at a 1.1% compound annual growth rate (CAGR), from 89.6% to 92.6%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Axsome Therapeutics's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude